Drug intelligence / Profile preview

glycerin 0.9%

Development stage
Unknown
Modality
Small Molecules
Administration
Ophthalmic
01

Overview

Glycerin 0.9% is a pharmaceutical formulation containing 0.9% (w/v) of the active ingredient glycerin (also known as glycerol or glycerine). Glycerin is a trihydroxy alcohol used in medicine primarily for its osmotic and lubricating properties. In ophthalmic preparations, such as artificial tears or lubricating eye drops, it acts as an ocular lubricant to relieve symptoms of dry eyes by retaining moisture on the ocular surface and protecting against irritation from environmental factors like wind or sun[3][8]. It may also be used to reduce intraocular pressure in conditions such as glaucoma due to its ability to create an osmotic gradient that draws fluid out of the eye[1][5]. When administered orally or rectally at higher concentrations, it serves as an osmotic laxative by drawing water into the intestines and stimulating bowel movements[2][4]. The mechanism of action in ophthalmic use is primarily physical lubrication and hydration; systemically, it works via osmosis.

Brand names
OsmoglynGlycerinBackQuality Choice Lubricating Eye Drops
Other names
glycerol 0.9%glycerine 0.9%

Beyond the preview

Go deeper on glycerin 0.9%.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on glycerin 0.9%.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call